Updated · The Australian Financial Review · May 24
Permira Sells I-MED to Jardine Matheson for $3.4 Billion, Scrapping Planned Float
Updated
Updated · The Australian Financial Review · May 24
Permira Sells I-MED to Jardine Matheson for $3.4 Billion, Scrapping Planned Float
10 articles · Updated · The Australian Financial Review · May 24
$3.4 billion is the enterprise value Jardine Matheson agreed to pay for I-MED, ending what had been touted as one of the year's biggest IPO candidates.
The weekend deal gives Jardine Matheson 100% ownership of I-MED, the largest radiology business in the Asia-Pacific region.
Permira, the London buyout firm exiting the asset, is expected to see the transaction announced in London on Monday at about 8 p.m. Sydney time.
Why did a $3.4B private sale beat a public offering for Asia's top radiology giant?
Will new ownership supercharge I-MED's AI revolution or just chase profits in healthcare?